2023 Q4 Form 10-K Financial Statement

#000095017024039494 Filed on April 01, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $221.9K $1.186M
YoY Change -1.54% 20.77%
Operating Profit -$1.186M
YoY Change 20.77%
Interest Expense $1.098M $7.771M
YoY Change -46.4% 116.34%
% of Operating Profit
Other Income/Expense, Net $550.3K $8.154M
YoY Change -46.43% -24.28%
Pretax Income $1.426M $6.968M
YoY Change -49.96% -28.8%
Income Tax
% Of Pretax Income
Net Earnings $1.426M $6.968M
YoY Change -49.96% -28.8%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.09 $0.30
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $320.1K $320.1K
YoY Change 11.13% 11.13%
Cash & Equivalents $0.00
Short-Term Investments
Other Short-Term Assets $26.48K $26.48K
YoY Change -94.41% -94.41%
Inventory
Prepaid Expenses $26.48K
Receivables
Other Receivables
Total Short-Term Assets $346.6K $346.6K
YoY Change -54.52% -54.51%
LONG-TERM ASSETS
Property, Plant & Equipment $83.85M $83.85M
YoY Change -62.75% -62.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $83.85M $83.85M
YoY Change -62.75% -62.75%
TOTAL ASSETS
Total Short-Term Assets $346.6K $346.6K
Total Long-Term Assets $83.85M $83.85M
Total Assets $84.20M $84.20M
YoY Change -62.72% -62.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.80K $27.80K
YoY Change -75.44% -75.44%
Accrued Expenses $546.0K $546.0K
YoY Change 17.92% 17.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $1.500M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.074M $2.074M
YoY Change 259.89% 259.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $550.3K $550.3K
YoY Change -31.82% -31.82%
Total Long-Term Liabilities $550.3K $550.3K
YoY Change -31.82% -31.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.074M $2.074M
Total Long-Term Liabilities $550.3K $550.3K
Total Liabilities $5.624M $5.624M
YoY Change -37.92% -37.92%
SHAREHOLDERS EQUITY
Retained Earnings -$5.278M
YoY Change -36.21%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.277M $78.58M
YoY Change
Total Liabilities & Shareholders Equity $84.20M $84.20M
YoY Change -62.72% -62.72%

Cashflow Statement

Concept 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $1.426M $6.968M
YoY Change -49.96% -28.8%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$147.9K -$717.9K
YoY Change 276.05% -66.14%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$379.5K $149.0M
YoY Change -167.27%
Cash From Investing Activities -$379.5K $149.0M
YoY Change -167.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $149.8M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 519.5K -148.3M
YoY Change -166.25%
NET CHANGE
Cash From Operating Activities -147.9K -717.9K
Cash From Investing Activities -379.5K 149.0M
Cash From Financing Activities 519.5K -148.3M
Net Change In Cash -7.940K 32.06K
YoY Change -79.82% -79.47%
FREE CASH FLOW
Cash From Operating Activities -$147.9K -$717.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001852061
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-41239
CY2023 dei Entity Registrant Name
EntityRegistrantName
GENERATION ASIA I ACQUISITION LIMITED
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1588665
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
Boundary Hall
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Cricket Square
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Grand Cayman
CY2023 dei Entity Address Country
EntityAddressCountry
KY
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
KY1-1102
CY2023 dei City Area Code
CityAreaCode
345
CY2023 dei Local Phone Number
LocalPhoneNumber
814-5580
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 dei Entity Public Float
EntityPublicFloat
230703600
CY2023 dei Auditor Firm
AuditorFirmId
5395
CY2023 dei Auditor Name
AuditorName
Marcum Asia CPAs LLP
CY2023 dei Auditor Location
AuditorLocation
New York, NY
CY2023Q4 us-gaap Cash
Cash
320144
CY2022Q4 us-gaap Cash
Cash
288081
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
26481
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
473993
CY2023Q4 us-gaap Assets Current
AssetsCurrent
346625
CY2022Q4 us-gaap Assets Current
AssetsCurrent
762074
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
22882
CY2023Q4 gaq Investments Held In Trust Account Noncurrent
InvestmentsHeldInTrustAccountNoncurrent
83854821
CY2022Q4 gaq Investments Held In Trust Account Noncurrent
InvestmentsHeldInTrustAccountNoncurrent
225084808
CY2023Q4 us-gaap Assets
Assets
84201446
CY2022Q4 us-gaap Assets
Assets
225869764
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
546000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
463045
CY2023Q4 gaq Promissory Note Related Party
PromissoryNoteRelatedParty
1500000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
27801
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
113184
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2073801
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
576229
CY2023Q4 gaq Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
550320
CY2022Q4 gaq Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
807136
CY2023Q4 gaq Deferred Underwriting Commissions
DeferredUnderwritingCommissions
3000000
CY2022Q4 gaq Deferred Underwriting Commissions
DeferredUnderwritingCommissions
7675500
CY2023Q4 us-gaap Liabilities
Liabilities
5624121
CY2022Q4 us-gaap Liabilities
Liabilities
9058865
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
7699729
CY2023Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.89
CY2022Q4 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
21930000
CY2022Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.26
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
7699729
CY2022Q4 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
21930000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5278244
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8274657
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5277496
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8273909
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84201446
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
225869764
CY2023 us-gaap Operating Expenses
OperatingExpenses
1185903
CY2022 us-gaap Operating Expenses
OperatingExpenses
981991
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-1185903
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-981991
CY2023 us-gaap Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
7770553
CY2022 us-gaap Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
3591808
CY2022 gaq Transaction Costs Allocable To Warrants
TransactionCostsAllocableToWarrants
-1004142
CY2023 gaq Gain Loss From Debt Forgiven
GainLossFromDebtForgiven
126472
CY2023 gaq Unrealized Gain On Fair Value Changes Of Warrants
UnrealizedGainOnFairValueChangesOfWarrants
256816
CY2022 gaq Unrealized Gain On Fair Value Changes Of Warrants
UnrealizedGainOnFairValueChangesOfWarrants
8181424
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8153841
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10769090
CY2023 us-gaap Net Income Loss
NetIncomeLoss
6967938
CY2022 us-gaap Net Income Loss
NetIncomeLoss
9787099
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-33457
CY2022 gaq Adjustments To Additional Paid In Capital Shares Transferred To Investor
AdjustmentsToAdditionalPaidInCapitalSharesTransferredToInvestor
14272
CY2022 gaq Adjustments To Additional Paid In Capital Excess Of Proceeds From Sale Of Private Placement Warrants Over Fair Value
AdjustmentsToAdditionalPaidInCapitalExcessOfProceedsFromSaleOfPrivatePlacementWarrantsOverFairValue
3763290
CY2022 gaq Adjustments To Additional Paid In Capital Incentives To Anchor Investors
AdjustmentsToAdditionalPaidInCapitalIncentivesToAnchorInvestors
10290473
CY2022 gaq Adjustments To Additional Paid In Capital Re Measurement Of Carrying Value To Redemption Value
AdjustmentsToAdditionalPaidInCapitalReMeasurementOfCarryingValueToRedemptionValue
-32095586
CY2022 us-gaap Net Income Loss
NetIncomeLoss
9787099
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8273909
CY2023 gaq Adjustments To Additional Paid In Capital Re Measurement Of Carrying Value To Redemption Value
AdjustmentsToAdditionalPaidInCapitalReMeasurementOfCarryingValueToRedemptionValue
-8520553
CY2023 gaq Adjustments To Additional Paid In Capital Forgiven Of Deferred Underwriter Commissions
AdjustmentsToAdditionalPaidInCapitalForgivenOfDeferredUnderwriterCommissions
4549028
CY2023 us-gaap Net Income Loss
NetIncomeLoss
6967938
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5277496
CY2023 us-gaap Profit Loss
ProfitLoss
6967938
CY2022 us-gaap Profit Loss
ProfitLoss
9787099
CY2023 gaq Interest Earned On Investment Held In Trust Account
InterestEarnedOnInvestmentHeldInTrustAccount
7770553
CY2022 gaq Interest Earned On Investment Held In Trust Account
InterestEarnedOnInvestmentHeldInTrustAccount
3591808
CY2022 gaq Transaction Costs Incurred In Connection With Initial Public Offering
TransactionCostsIncurredInConnectionWithInitialPublicOffering
1004142
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-256816
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8181424
CY2023 gaq Gain Loss From Debt Forgiven
GainLossFromDebtForgiven
126472
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-470394
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
496875
CY2023 gaq Increase Decrease In Accrued Offering Costs And Expenses
IncreaseDecreaseInAccruedOfferingCostsAndExpenses
82955
CY2022 gaq Increase Decrease In Accrued Offering Costs And Expenses
IncreaseDecreaseInAccruedOfferingCostsAndExpenses
-710905
CY2023 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-85383
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
69767
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-717937
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2120004
CY2023 gaq Payments To Acquire Investments Held In Trust Account
PaymentsToAcquireInvestmentsHeldInTrustAccount
458877047
CY2022 gaq Payments To Acquire Investments Held In Trust Account
PaymentsToAcquireInvestmentsHeldInTrustAccount
888533773
CY2023 gaq Proceeds From Disposal Of Investments Held In Trust Account
ProceedsFromDisposalOfInvestmentsHeldInTrustAccount
608627587
CY2022 gaq Proceeds From Disposal Of Investments Held In Trust Account
ProceedsFromDisposalOfInvestmentsHeldInTrustAccount
667041000
CY2023 gaq Payment To Cash Deposited In Trust Account
PaymentToCashDepositedInTrustAccount
750000
CY2022 gaq Payment To Cash Deposited In Trust Account
PaymentToCashDepositedInTrustAccount
227
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
149000540
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-221493000
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
216894000
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
7379000
CY2022 gaq Proceeds From Anchor Investor
ProceedsFromAnchorInvestor
14272
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1500000
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
275000
CY2022 gaq Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
243099
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
149750540
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-148250540
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
223769173
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32063
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
156169
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
288081
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
131912
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
320144
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
288081
CY2023 gaq Waiver Of Deferred Underwriting Commissions
WaiverOfDeferredUnderwritingCommissions
4549028
CY2022 gaq Deferred Underwriting Commissions Charged To Additional Paid In Capital
DeferredUnderwritingCommissionsChargedToAdditionalPaidInCapital
7675500
CY2022 gaq Initial Value Of Stock Subject To Possible Redemption
InitialValueOfStockSubjectToPossibleRedemption
192989222
CY2023 gaq Re Measurement Of Carrying Value Of Shares Subject To Possible Redemption To Redemption Value
ReMeasurementOfCarryingValueOfSharesSubjectToPossibleRedemptionToRedemptionValue
8520553
CY2022 gaq Re Measurement Of Carrying Value Of Shares Subject To Possible Redemption To Redemption Value
ReMeasurementOfCarryingValueOfSharesSubjectToPossibleRedemptionToRedemptionValue
32095586
CY2022 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
8988560
CY2022 gaq Incentive To Anchor Investors In Noncash Transactions
IncentiveToAnchorInvestorsInNoncashTransactions
10290473
CY2023Q2 gaq Waived Deferred Underwriting Commissions
WaivedDeferredUnderwritingCommissions
4675500
CY2023 gaq Redemption Percentage Of Public Shares
RedemptionPercentageOfPublicShares
1
CY2023 gaq Amount Of Interest To Pay Dissolution Expenses
AmountOfInterestToPayDissolutionExpenses
100000
CY2023Q4 gaq Amount In Trust Account Per Public Share
AmountInTrustAccountPerPublicShare
10.1
CY2023 gaq Redemption Percentage Of Public Shares
RedemptionPercentageOfPublicShares
1
CY2023 gaq Amount Of Interest To Pay Dissolution Expenses
AmountOfInterestToPayDissolutionExpenses
100000
CY2023Q4 gaq Amount In Trust Account Per Public Share
AmountInTrustAccountPerPublicShare
10.1
CY2023 gaq Redemption Percentage Of Public Shares
RedemptionPercentageOfPublicShares
1
CY2023Q4 gaq Amount In Trust Account Per Public Share
AmountInTrustAccountPerPublicShare
10.1
CY2023Q4 gaq Amount In Trust Account Per Public Share
AmountInTrustAccountPerPublicShare
10.1
CY2023Q4 gaq Amount In Trust Account Per Public Share
AmountInTrustAccountPerPublicShare
10.1
CY2023Q3 gaq Business Combination Deposit To Trust Account By Related Parties
BusinessCombinationDepositToTrustAccountByRelatedParties
723690
CY2023Q3 us-gaap Share Price
SharePrice
0.03
CY2023Q3 gaq Business Combination Deposit To Trust Account By Related Parties
BusinessCombinationDepositToTrustAccountByRelatedParties
125000
CY2023Q3 gaq Business Combination Aggregate Deposit To Trust Account By Related Parties
BusinessCombinationAggregateDepositToTrustAccountByRelatedParties
1125000
CY2023Q4 us-gaap Cash
Cash
320144
CY2023Q4 gaq Working Capital Deficit
WorkingCapitalDeficit
1720456
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="margin-left:2.627%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability and over-allotment liability. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates.‌</span></p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Concentration of Credit Risk‌</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">250,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company has not experienced losses on this account.‌</span></p>
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2023Q4 us-gaap Cash
Cash
320144
CY2022Q4 us-gaap Cash
Cash
288081
CY2023Q2 gaq Waived Deferred Underwriting Commissions
WaivedDeferredUnderwritingCommissions
4675500
CY2023Q2 gaq Waived Deferred Underwriting Commissions
WaivedDeferredUnderwritingCommissions
4675500
CY2023Q3 gaq Temporary Equity Redeemed During Period Value
TemporaryEquityRedeemedDuringPeriodValue
149750000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
27801
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
113184
CY2022Q1 us-gaap Payment For Administrative Fees
PaymentForAdministrativeFees
10000
CY2022Q1 gaq Gross Proceeds From Over Allotment Option
GrossProceedsFromOverAllotmentOption
19300000
CY2023Q2 gaq Waived Deferred Underwriting Commissions
WaivedDeferredUnderwritingCommissions
4675500
CY2023Q4 gaq Remaining Deferred Underwriting Commissions
RemainingDeferredUnderwritingCommissions
3000000
CY2023Q4 gaq Payable To Underwriter In Cash
PayableToUnderwriterInCash
1000000
CY2023Q4 gaq Payable To Underwriter In Share
PayableToUnderwriterInShare
200000
CY2023Q4 gaq Nominal Value Price Per Share
NominalValuePricePerShare
10
CY2023Q4 gaq Aggregate Nominal Value
AggregateNominalValue
2000000
CY2023Q2 gaq Waived Deferred Underwriting Commissions
WaivedDeferredUnderwritingCommissions
4675500
CY2023Q4 gaq Deferred Underwriting Commissions
DeferredUnderwritingCommissions
3000000
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
83854821
CY2023Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
550320
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
225084808
CY2022Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
807136
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0

Files In Submission

Name View Source Status
0000950170-24-039494-index-headers.html Edgar Link pending
0000950170-24-039494-index.html Edgar Link pending
0000950170-24-039494.txt Edgar Link pending
0000950170-24-039494-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gaq-20231231.htm Edgar Link pending
gaq-20231231.xsd Edgar Link pending
gaq-ex10_11.htm Edgar Link pending
gaq-ex10_12.htm Edgar Link pending
gaq-ex31_1.htm Edgar Link pending
gaq-ex31_2.htm Edgar Link pending
gaq-ex32_1.htm Edgar Link pending
gaq-ex32_2.htm Edgar Link pending
gaq-ex97_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
gaq-20231231_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable